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UTILITY OF PHYLLOPLANINS AS 
ANTIBIOTICS, SELECTIVE FUNGICIDES 
AND FOR ENHANCING MICROBIAL 
RESISTANCE IN PLANTS 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
This application is a continuation in part of application Ser. 
No. 11/304,528, ?led Dec. 15, 2005, which claims priority 
under 35 U.S.C. §119 to US. Provisional Application Ser. 
No. 60/682,814, ?led May 20, 2005, the disclosures ofwhich 
are incorporated herein by reference. 
TECHNICAL FIELD 
Methods of producing and using compositions useful as 
antimicrobial agents are provided. More particularly, these 
compositions involve the use of phylloplanin proteins. 
BACKGROUND 
The need for new antimicrobial agents that prevent or treat 
plant and animal diseases increases as pathogens gain resis 
tance to existing antimicrobials. In agriculture, available 
approaches for inhibiting and preventing crop and seed loss 
due to fungal diseases are inadequate in many cases. Fungi, 
e.g., basidiomycetes and ascomycetes, and fungi-like patho 
gens, e. g., oomycete, are signi?cant causes of disease in many 
seeds and plants, including tobacco, grains, fruits, and veg 
etables, as well as grasses, e.g., turfgrass. In 1979, an epi 
demic of blue mold (caused by the oomycete Peronospora 
tabacina) caused an estimated $1.1 billion loss of tobacco 
crops in Ontario. 
Furthermore, the use some currently marketed topical fun 
gicides have drawbacks, e.g., some are thought to be hazard 
ous to the environment, toxic to mammals, or raise other 
public concerns (e.g., concerns about the possible estrogenic 
properties of “natural” paraben preservatives in cosmetics). 
Thus there is a need for alternative natural antimicrobial 
agents that do not have these perceived disadvantages. 
SUMMARY 
This invention provides a family of phylloplanins, plant 
proteins produced by a plant’ s epidermal layer that contribute 
to the innate pest/disease resistance of the plant. Phyl 
loplanins are produced by and secreted to the aerial surfaces 
of many higher plants and vary in molecular siZe and other 
properties. A phylloplanin described herein was ?rst identi 
?ed by washing Nicotiana tabacum leaves with water, lyo 
philiZing the wash solution, resuspending the lyophiliZed 
material in water to give a leaf water wash (LWW) sample, 
and analyZing LWW by SDS-PAGE (FIG. 1). As described 
herein, phylloplanins from tobacco (Shepherd et al., The 
Plant Cell 17: 1851-1861, 2005; Trends in Plant Science 12: 
51-56, 2007; Plant Physiology, 144), sun?ower, e.g. Helian 
thus annus, and Datura, e.g., Datura metel, inhibit gerrnina 
tion and growth of the blue mold pathogen (belonging to the 
oomycete, a fungus-like pathogen class), and Pyricularia 
grisea, a basidiomycete class fungus that causes grey leaf 
spot on turf grasses, and phylloplanins from tobacco and 
sun?ower also inhibit the germination and growth of Rhizc 
tonia solani, an ascomycete class fungus that causes Brown 
Patch disease on turf grasses and Target Spot disease on 
tobacco. Thus, phylloplanin polypeptides of this invention 
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2 
have broad-spectrum anti-fungal activity (active against 
pathogens from three of the 4 major classes of fungal patho 
gens). 
This invention relates to phylloplanin polypeptides, sub 
stantially puri?ed phylloplanin polypeptides and composi 
tions comprising phylloplanin polypeptides, particularly 
phylloplanin polypeptides from broadleaf plants, e. g., 
tobacco, sun?ower and Datura, that have antimicrobial activ 
ity, particularly a broad spectrum anti-fungal activity. Anti 
fungal as used herein refers to inhibition of germination and/ 
or growth of fungi, e.g., ascomycetes and basidiomycetes, 
and fungi-like organisms, e.g., oomycetes. In one aspect of 
this invention the phylloplanin polypeptides, in their natural 
state, are hydrophobic, basic and often glycosylated, and may 
have a molecular weight of from about 10 kD to about 75 kD, 
preferably about 10 kD to about 30 kD. The phylloplanin 
polypeptides of this invention isolated from plants and com 
positions comprising the phylloplanin polypeptides inhibit 
germination and/ or growth of fungi and fungi-like organisms, 
preferably basidiomycetes, ascomycetes and/or oomycetes. 
Also an aspect of this invention are compositions compris 
ing the phylloplanin polypeptides or substantially puri?ed 
phylloplanin polypeptides of this invention and variants or 
fragments thereof. Preferably the compositions of this inven 
tion comprise a polypeptide having the amino acid sequence 
set forth in SEQ ID NO: 18, or a fragment of SEQ ID NO: 18 
having antimicrobial activity, for example the sequence 
encompassed by amino acids residues 22-150, 23-150 or 
24-150 of SEQ ID NO: 18. The compositions may also com 
prise a polypeptide having the amino acid set forth in SEQ ID 
NO: 38 or a fragment of SEQ ID NO:18 having antimicrobial 
activity. The compositions may also comprise a variant of 
these phylloplanin polypeptides or fragment thereof. The 
phylloplanin polypeptides, substantially puri?ed phyllopla 
nin polypeptides and compositions comprising phylloplanin 
polypeptides or fragments or variants thereof having antimi 
crobial activity are suitable for suppressing microbial growth 
on a subject, an organism or a surface that is susceptible to 
fungal infection (e. g., plants and animals). 
The phylloplanin polypeptides, substantially puri?ed phyl 
loplanin polypeptides and compositions comprising the phyl 
loplanin polypeptides of this invention, or fragments or vari 
ants thereof having antimicrobial activity, may be used to 
inhibit microbial growth, particular germination or growth of 
a fungus and a fungus-like organism, on plants or their seeds, 
that are susceptible to infection by the microbes. Thus, also an 
aspect of this invention are compositions useful for treating 
plants that are susceptible to microbial infections wherein the 
compositions comprise proteins consisting essentially of 
phylloplanins having anti microbial, particularly anti-fungal, 
activity and preferably phylloplanins of tobacco, sun?ower or 
Datura. The plants may be treated prior to, or subsequently, to 
infection with the microbe to inhibit progression of the dis 
ease. 
A variant of the polypeptides of this invention may contain 
conservative substitutions of amino acids within the 
sequence, but is at least 80% identical, preferably greater than 
80% identical, more preferably at least 90% identical and 
most preferably at least 95% identical, to SEQ ID NO:18, or 
to a fragment of SEQ ID NO: 18, having antimicrobial activity 
(for example the sequences encompassed by amino acids 
residues 22-150, 23-150 or 24-150 of SEQ ID NO:18), and is 
at least 50%, preferably at least 70%, more preferably at least 
80% and most preferably at least 90% as effective as an equal 
molar amount of SEQ ID NO:18 in inhibiting germination 
and/or growth of a fungus or fungus-like organism, e. g., 
US 8,227,573 B2 
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basidiomycetes, ascomycetes and/or oomycetes, on a subject, 
organism or surface, e. g., an animal or plant. 
This invention also relates to an isolated nucleic acid mol 
ecule comprising the polynucleotide sequence set forth in 
SEQ ID NO: 17 or the portion ofSEQ ID NO: 17 that encodes 
the amino acid sequence of residues 22-150, 23-150 or 
24-150 of SEQ ID NO: 18, or a homolog thereof With >80% 
identity preferably at least 90% identity and more preferably 
at least 95% identity. The invention further relates to a 
polypeptide encoded by the polynucleotide sequence of SEQ 
ID NO: 17 or a homolog thereof With >80% identity, prefer 
ably at least 90% identity and more preferably at least 95% 
identity e.g., SEQ ID NO:18, that have antimicrobial activity. 
The invention further relates to a polypeptide encoded by the 
polynucleotide sequence of SEQ ID NO: 17 or homologs 
thereof, that encodes the amino acid sequence of residues 
22-150, 23-150 or 24-150 of SEQ ID NO:18. 
The invention further relates to a method of inhibiting 
microbial proliferation in or on a plant, e.g., by overexpres 
sion of a phylloplanin gene in the plant, or contacting an 
infected plant With a phylloplanin polypeptide, and in or on a 
surface by contacting the surface With a phylloplanin 
polypeptide. 
The invention further provides a novel promoter sequence 
that is useful for expression of a protein of interest in a host 
cell, e.g., a plant cell. In accordance With the invention, a 
nucleic acid construct is provided comprising a non-coding 
regulatory domain isolated from a phylloplanin gene, 
Wherein said non-coding regulatory domain is operably asso 
ciated With a nucleic acid molecule having a sequence Which 
encodes a protein of interest, Wherein said nucleic acid mol 
ecule is heterologous to said non-coding regulatory domain, 
and Wherein the non-coding regulatory domain comprises a 
sequence at least 80% identical to the sequence set forth in 
SEQ ID NO:34. The construct comprises a transcriptional 
and translational initiation region and translational termina 
tion region functional in plants. 
The invention further relates to plants selected from the 
group consisting of corn, soybean, tobacco, potato, tomato, 
pepper, Datura, alfalfa, cucumber, medicago, vitis sp and 
grasses, e. g., turf grasses and the like, genetically modi?ed by 
a polypeptide of the invention. 
The invention further relates to a method of inhibiting 
microbial proliferation in or on an organism comprising 
administering a therapeutically effective amount of a phyl 
loplanin polypeptide. 
The invention further relates to a method of screening 
endogenous proteins from a plant leaf surface for antimicro 
bial properties, the method comprising a) Washing the plant 
leaf surface With an aqueous solution; b) collecting the aque 
ous solution after Washing; and c) analyZing the solution for 
proteins having antimicrobial, e.g., antibacterial or antifun 
gal, properties. 
The invention further relates to methods of screening 
endogenous plant proteins for antimicrobial activity, com 
prising obtaining the proteins from a plant, e.g., the leaf 
surfaces, for antimicrobial activity. Preferably the proteins 
are obtained from of a species selected from the group con 
sisting of Medicago sp., Trifalium sp., Ulmus sp., Pyrus 
malus, Prunus armeniaca, Cynara acalymus, Asparagus o?i 
cinale, Hordeum sp., Galium sp., Beta vulgaris, Prunus sero 
tina, I/igna sinensis, Nyssa sylvatica, Quercus sp., Artocarpus 
altilis, Brassica sp., Andropogon scoparius, Fagopyrum sag 
ittatum, Manihot esculenta, Apium graveolens, Agropyron 
desertorum, C0rnus ?orida, Phaseolus sp., T riticum sp., 
Oenothera caespitosa, Carya sp., Lactuca sp., Impatiens sp., 
Helianthus sp., Ledum decumbens, Astragalus pattersoni, 
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Setaria italica, Vaccinium mytrillus, Avena sativa, Petroseli 
num crispum, Pastinaca sativa, Pisum sp., Prunus sp., Pyrus 
communis, Musaparadisiaca, Astragaluspreussii, Raphanus 
sativus, Secalse cereale, Sassafras albidum, Atriplex confer 
tifolia, Zillandsia usneoides, Spinacia oleracea, Liquidam 
bar styraci?ua, Linaria triphylla, Liriodendron tulipfera, 
I/icia sp., Citrullus vulgaris, Melilotus sp., Salix sp., Rhus 
copallina, Nicotiana sp., I/itis sp., Datura sp., Medicago sp., 
Lycopersicon sp., Solanum sp., Capsicum sp., Cucumis sp., 
Fragaria sp., Petunia sp., Geranium sp., Coleus sp., Stevia 
sp., Oryza sp., Nepeta sp., Zea mays, Glycine max, and 
assayed for antimicrobial activity, preferably anti-fungal 
activity, and more preferably for the ability to inhibit germi 
nation and/or groWth of an oomycetes, a basidiomycetes or an 
ascomycetes, e. g., R tabacina, Pyricularia grisea, and Rhizc 
t0nia s0lani. 
Phylloplanins are persistent on leaf surfaces and therefore 
do not appear to be light sensitive. 
Although We do not knoW if the phylloplanins of this 
invention are toxic to animals, surface proteins occur on many 
vegetables, Which are consumed fresh (lettuce, cabbage) by 
mammals, and several spice species that are used as fresh and 
dry-leaf food additives Without adverse effects. The toxicity 
of phylloplanins for mammals and other animals may be 
readily assayed using conventional techniques and if they are 
found to be toxic, suitable precautions may easily be insti 
tuted to reduce exposure of mammals or other animals to the 
phylloplanins. 
The invention provides phylloplanin polypeptides, sub 
stantially pure phylloplaninin polypeptides and variants and 
fragments thereof, having antimicrobial activity, preferably 
anti-fungal activity, and methods of using such polypeptides 
and compositions comprising such polypeptides, to enhance 
microbial, preferably fungal, resistance in plants. In addition, 
the invention demonstrates that the phylloplanin polypeptides 
of this invention are antimicrobial proteins useful in molecu 
lar farming products. Phylloplanins have the potential to be 
used as antibiotics against human and animal microorgan 
isms. Overexpression of phylloplanin genes in plants such as 
corn, soybean, tobacco, tomato, potato, pepper, Datura, 
alfalfa, cucumber, medicaga, vitis sp, grasses, e.g., turfgrass, 
and the like enhances plant resistance to fungal and bacterial 
microorganisms. In addition, the phylloplanin polypeptides 
of this invention can be used as a topical fungicide. 
Other aspects of the invention are described throughout the 
speci?cation. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. lA-C depicts data demonstrating proteins present on 
plant leaf surfaces. A: 40>< magni?cation of TI 1068 phyl 
loplane With tall glandular secreting trichomes (TGSTs) and 
short glandular trichome (SGTs) identi?ed. B: Coomassie 
stained SDS-PAGE of TI 1068-derived samples. Phyl 
loplanins I-IV are identi?ed. Loaded volumes of leaf Water 
Wash (LWW) (B,d) and sterile-grown plant LWW (B,e) rep 
resent 25 cm2 leaf surface area. MWt (B,a) denotes protein 
standards. C: Silver-stained SDS-PAGE of LWWs from ?eld 
groWn TI 1068 (C,b; 10 cm2), G. max (C,c; 30 cm2), and H. 
annuus (C,d; 6 cm2). MWt (C,a) denotes protein standards. 
FIG. 2A-B depicts proteins in TI 1068 LWW that inhibit R 
tabacina spore germination and leaf infection. A: P tabacina 
spore germination assays (Pt), Coomassie-stained SDS 
PAGE (sds), and Western blots With 1:10,000 phylloplanin 
antiserum (W). a, Water+spores. b, TI 1068 LWW (diluted to 
100 ng/ul total protein)+spores. c, TI 1068 LWW (100 ng/ul 
total protein) digested With Proteinase K (ProtK)+spores. 
US 8,227,573 B2 
5 
Arrow marks residual, soluble ProtK. B: P Zabacina leaf 
infection assay of Petite Havana. a, water+spores (104 spores/ 
ml). A sporulating lesion is indicated with arrow. b, TI 1068 
LWW (diluted to 50 ng/ul)+spores (104 spores/ml). 
FIG. 3 provides a nucleotide sequence (SEQ ID NO:17) 
and predicted amino acid sequence (SEQ ID NO:18) of TI 
1068 Phylloplanin. Nucleotides are numbered on right. Start 
and stop codons are underlined, and the signal sequence is 
bold-faced. Segments corresponding to peptides amino acid 
N1, amino acid-T1, amino acid-T2, amino acid-T3, amino 
acid-T4, and amino acid-P1 are marked by lines above the 
amino acid sequence and labeled. 
FIG. 4A-D demonstrates E. cob-expressed TI 1068 phyl 
loplanin inhibition of R Zabacina spore germination. Coo 
massie-stained SDS-PAGE (sds), western blots with 1 : 10,000 
phylloplanin antiserum (W), and R Zabacina spore germina 
tion assays (Pt). a: E. coli expressed MBP-PhyllP (M-P; 160 
ng/ul total protein) treated with Factor-Xa. Arrow indicates 
released PhyllP. b: E. coli expressed MBP-PhyllP (160 ng/ul 
total protein) treated with Factor-Xa and Proteinase-K 
(ProtK). Volume used was equivalent to (a). c: E. coli 
expressed MBP (M; 200 ng/ul total protein treated with Fac 
tor-Xa. d: E. coli expressed MBP (200 ng/ul total protein) 
treated with Factor-Xa and ProtK Volume used was equiva 
lent to (c). 
FIG. 5A-C shows that the phylloplanin promoter directs 
protein expression in short glandular trichomes (SGTs). A: 
Magni?cation of X-gluc stained plantlet leaf from TI 1068 
with GUS under control of phylloplanin promoter. Tall glan 
dular secreting trichomes (TSGTs) are also indicated. B: 
X-gluc stained SGT on TI 1068 plantlet expressing GUS 
under control of phylloplanin promoter. Surface structures 
are indicated. C: Fluorescent magni?cation/detection of TI 
1068 plantlet with GFP under control of phylloplanin pro 
moter. GFP was present only in SGT gland cells. The yellow 
arrows indicate constrictions between gland cells that may be 
“pores” to release protein to the leaf surface. 
FIG. 6 depicts growth curves of E. coli BL21 cultures 
expressing N. Zabacum PR-5a and A. Zhaliana AAP75801 
with the pET-30 system. Induction with IPTG, if performed, 
occurred at 2.25 hrs. The IPTG-induced PR-5a expressing 
culture continued logarithmic growth along with control 
BL21 cells and non-IPTG-induced cultures. The IPTG-in 
ducedAAP75801 expressing culture seemed to stop growing. 
This suggests that the induced AAP75801 protein product 
was toxic towards the culture. 
FIG. 7 depicts inhibition of R Zabacina Spore Germination 
and Leaf Infection by T-Phylloplanins in LWW. For both 
assays, the results of a single experiment that is representative 
of three separate experiments are shown. Open circles, spore 
germination; closed squares, leaf infection. 
FIG. 8A-B depicts multiple alignment and phylogenetic 
analysis of T-phylloplanin and similar sequences in other 
plants (SEQ ID NOs: 18 and 36-48, respectively). A: The 
amino acid sequence of T-phylloplanin was aligned against 
sequences giving signi?cant BLAST similarity scores using 
the ClustalW algorithm of DNASTAR (Lasergene Software, 
Madison, Wis.). Amino acids conserved between any six 
sequences are indicated in reverse contrast. B: Unrooted phy 
logenetic tree showing the evolutionary relationships 
between the sequences in (A). Bootstrap values of >50% are 
given on the respective branches. The ?rst two letters of the 
acronyms indicate the species (Am, Anlirrhinum majus; At, 
Arabidopsis Zhaliana; Br, Brassica rapa; Gm, Glycine max; 
Ha, Helianlhus annuus; Le, Lycopersicon eschulenlum; Nt, 
Nicoliana Zabacum; Os, Oryza saliva; Pt, Populus [remu 
loides; Sr, Slevia rebaudiana; St. Slevia luberosum). The 
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GenBank accession numbers of the sequences follow the 
species identi?ers. Tissue localiZations of ESTs and cDNAs 
are indicated beneath the acronyms. 
FIG. 9 depicts the promoter sequence of the gene Phyl 
loplanin (SEQ ID NOS:49 and 50). A putative TATA box 
(2-33 to —30) and a putative CAAT box (—47 to —43) are 
bold-faced. The phylloplanin transcription start site (+1) is 
bold-faced and underlined. The phylloplanin start codon 
(+48) is underlined. A portion of the phylloplanin amino acid 
sequence is indicated. 
FIG. 10A-E depicts the effects of spraying LWW contain 
ing T-phylloplanin on grasses prior to inoculation with myce 
lia ofPyricularia grisea (A, B) orRhizcZonia solani (C, D, AR is annua  rye grass (Lolium mull ?'orum) (B), PR is peren 
nial rye grass (Lolium perenne) (A, D), and CB is creeping 
bentgrass (Agroslispaluslris) (C). T-phyllo is tobacco LWW 
containing T-phylloplanin. Pots labeled “a” (left) are phyl 
loplanin treated, Pots labeled “b” (center) are ProteinaseK 
digested phylloplanin treated, and Pots labeled “c” (right) are 
ProteinaseK control treated (no phylloplanin). Note the 
healthy growth in the left-most pots of each set, and deterio 
ration in the center and right situated pots where phylloplanin 
was protease pre-treated, or protease control was applied. 
Insets show symptoms of diseases on leaf blades of pot c, and 
healthy leaf blades in pot a. 
FIG. 11A-E depicts the effects of spraying LWW contain 
ing S-phylloplanin on grasses prior to inoculation with myce 
lia ofPyricularia grisea (A, B) orRhizcZonia solani (C, D, Designations are as d scribed in t e legend of FIG. 10. 
FIG. 12A-D: In vitro, petri-plate, ?lter-paper-disc assays 
of T-phylloplanin effects (A and B) and S-phylloplanin 
effects (C and D) on growth of Pyricularia grisea (A and C), 
or Rhizclonia solani (B and D). PristineTM (upper disc) was 
used as a positive inhibition control. Water (lower disc) was 
used as a solution control. LWWs containing T-, or S-phyl 
loplanins were applied in water. Phylloplanin pre-treated with 
ProteinaseK to destroy phylloplanins is at the left in each 
case, and phylloplanin not treated with ProteinaseK is at the 
right. ProteinaseK controls showed no inhibition (not shown). 
A clear Zone of inhibition (arrows) was observed with Pris 
tineTM and T-, or S-phylloplanin containing LWW in all cases. 
FIG. 13: Protease sensitivity of tobacco, jimson weed, 
sun?ower and soybean phylloplanins. Lane 1 contains M, 
markers. Lanes 2 and 3, tobacco LWW, + and — Proteinase K, 
respectively; lanes 4 and 5, sun?ower LWW, + and — Protein 
ase K, respectively; lanes 6 and 7, jimson weed LWW, + and 
— ProteinaseK, respectively; lanes 8 and 9, soybean LWW, + 
and — ProteinaseK, respectively. Protein bands at approxi 
mately 32 kD in lanes 2, 4, 6, and 8 are soluble ProteinaseK 
released during digestions. All samples contained 15 cm2asae 
of LWW. 
DETAILED DESCRIPTION 
The invention is directed to phylloplanin polypeptides hav 
ing antimicrobial, preferably antifungal, activity and to com 
positions comprising the phylloplanin polypeptides. The 
invention also relates to methods of using the phylloplanin 
polypeptides to inhibit microbial, preferably fungal and fun 
gus-like, infection and disease of plants and animals, prefer 
ably humans, and to inhibit the germination and growth of 
fungus and fungus like organisms in or on the surface of 
materials that are susceptible to infection by e.g., bacteria, 
fungus or fungus-like organisms. 
DEFINITIONS 
To facilitate understanding of the invention set forth in the 
disclosure that follows, a number of terms are de?ned below. 
US 8,227,573 B2 
7 
The term “innate immunity” refers to a defense system that 
inhibits growth of microorganisms at their ?rst point of con 
tact. 
The term “phylloplane” refers to a plant’s epidermal layer 
that contributes to the innate pest/disease resistance of the 5 
plant. 
The term “phylloplanins” refers to proteins produced by a 
plant’s epidermal layer that contribute to the innate pest/ 
disease resistance of the plant. 
The term “TGSTs” refers to the tall glandular secreting 10 
trichome. 
The term “SGTs” refers to the short glandular trichome. 
The term “LWW” refers to leaf water washes. 
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T-phylloplanin as used herein refer phylloplanins from 
tobacco. 
S-phylloplanin as used herein refer phylloplanins from 
sun?ower. 
D-phylloplanin as used herein refer phylloplanins from 
Datum. 
The meaning of other terminology used herein should be 
easily understood by someone of ordinary skill in the art. 
Fungicides are commonly used to inhibit fungal disease in 
plants, and are commercially available and used for prevent 
ing crop loss. Examples of such fungicides are listed in the 
following table. 
FRAC CHEMICAL COMMON 
CODEl TARGET SITE2 GROUP NAME3 GROUP4 NAMES COMMENTS6 
1 mitosis: [5-tubuline MBC — fungicides benzimidazoles Fuberidazole Resistance 
assembly (Methyl benomyl carbendazim thiabendazole common in 
Benzimidazole thiophanates many ?lngal 
Carbalnates) thiophanate species. 
thiophanate-methyl Several target 
site mutations, 
mostly 
El98NG/K, 
FZOOY Positive 
cross resistance 
between the 
group members. 
Negative cross 
resistance to N 
Phenylcarbarnates 
High risk. 
See FRAC 
BenZirnidaZole 
Guidelines for 
resistance 
management. 
2 NADH decarboximides chlozolinate Resistance 
cytochrome c iprodione common in 
reductase in lipid procymidone Bolryris cinerea 
peroxidation vinclozolin and found in 
(proposed) some other 
fungal species. 
Several mutations 
found in OSl 
histidine kinase 
(Daf l), mostly 
1365s Cross 
resistance common 
between the 
group members. 
Medium to high 
risk. See FRAC 
Dicarboximide 
Guidelines for 
resistance 
management. 
3 C14- DMI-fungicides imidazoles irnazalil pe?irazoate There are great 
dernethylation in (DeMethylation prochloraz differences in 
sterol biosynthesis Inhibitors) (SBI: tri?urnizole the activity 
Class I) triforine pyrifenox spectra of the 
piperazines pyridines fenarimol nuarimol different DMI 
pyrimidines azaconazole fungicides. 
bitertanol Resistance is 
triazoles brornuconazole known in 
cyproconazole various fungal 
difenoconazole species. 
diniconazole Several 
epoxiconazole resistance 
fenbuconazole mechanisms 
?uquinconazole known incl. 
?usilazole ?utriafol target site 
hexaconazole mutation 
imibenconazole YI36F, ABC 
ipconazole transporters and 
metconazole others. 



































